Giant Biogene Holding Co. Ltd.

  • Market Cap: N/A
  • Industry: FMCG
  • ISIN: KYG3887G1091
HKD
29.00
-0.62 (-2.09%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%

  • The company is Net-Debt Free
2

The company has declared negative results in Dec'2025 after 3 consecutive positive quarters

3

With ROE of 0.02%, it has a Very Expensive valuation with a 2.55 Price to Book Value

4

Underperformed the market in the last 1 year

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

FMCG

stock-summary
Market cap

HKD 28,284 Million ()

stock-summary
P/E

12,296.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.84

stock-summary
Return on Equity

-999,999.00%

stock-summary
Price to Book

2.56

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0.83%
0%
0.83%
6 Months
-19.04%
0%
-19.04%
1 Year
-51.67%
0%
-51.67%
2 Years
-29.7%
0%
-29.7%
3 Years
-17.38%
0%
-17.38%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Giant Biogene Holding Co. Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
22.36%
EBIT Growth (5y)
33.69%
EBIT to Interest (avg)
2.64
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.82
Sales to Capital Employed (avg)
11.53
Tax Ratio
37.90%
Dividend Payout Ratio
31.18%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
12296
Industry P/E
Price to Book Value
2.55
EV to EBIT
5474.37
EV to EBITDA
5131.19
EV to Capital Employed
10.43
EV to Sales
205.30
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
0.19%
ROE (Latest)
0.02%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Bearish
Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Giant Biogene Holding Co. Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -0.34% vs 54.21% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -7.11% vs 39.69% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,985.00",
          "val2": "6,005.30",
          "chgp": "-0.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,389.20",
          "val2": "2,527.40",
          "chgp": "-5.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.30",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "54.20",
          "val2": "46.90",
          "chgp": "15.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,076.50",
          "val2": "2,235.40",
          "chgp": "-7.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "384.30%",
          "val2": "411.90%",
          "chgp": "-2.76%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
5,985.00
6,005.30
-0.34%
Operating Profit (PBDIT) excl Other Income
2,389.20
2,527.40
-5.47%
Interest
0.30
0.30
Exceptional Items
54.20
46.90
15.57%
Consolidate Net Profit
2,076.50
2,235.40
-7.11%
Operating Profit Margin (Excl OI)
384.30%
411.90%
-2.76%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is -0.34% vs 54.21% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -7.11% vs 39.69% in Dec 2024

stock-summaryCompany CV
About Giant Biogene Holding Co. Ltd. stock-summary
stock-summary
Giant Biogene Holding Co. Ltd.
FMCG
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available